- Home
- BWAY vs BDTX Comparison
BWAY vs BDTX Comparison
Compare BWAY & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- BDTX
- Stock Information
- Founded
- BWAY 2003
- BDTX 2014
- Country
- BWAY Israel
- BDTX United States
- Employees
- BWAY N/A
- BDTX N/A
- Industry
- BWAY Medical/Dental Instruments
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWAY Health Care
- BDTX Health Care
- Exchange
- BWAY Nasdaq
- BDTX Nasdaq
- Market Cap
- BWAY 177.4M
- BDTX 144.9M
- IPO Year
- BWAY 2019
- BDTX 2020
- Fundamental
- Price
- BWAY $9.56
- BDTX $2.13
- Analyst Decision
- BWAY Strong Buy
- BDTX Strong Buy
- Analyst Count
- BWAY 3
- BDTX 4
- Target Price
- BWAY $13.17
- BDTX $15.50
- AVG Volume (30 Days)
- BWAY 46.4K
- BDTX 472.0K
- Earning Date
- BWAY 11-12-2024
- BDTX 11-05-2024
- Dividend Yield
- BWAY N/A
- BDTX N/A
- EPS Growth
- BWAY N/A
- BDTX N/A
- EPS
- BWAY 0.04
- BDTX N/A
- Revenue
- BWAY $38,631,000.00
- BDTX N/A
- Revenue This Year
- BWAY $378.91
- BDTX N/A
- Revenue Next Year
- BWAY $20.27
- BDTX N/A
- P/E Ratio
- BWAY $123.49
- BDTX N/A
- Revenue Growth
- BWAY 34.19
- BDTX N/A
- 52 Week Low
- BWAY $4.61
- BDTX $2.08
- 52 Week High
- BWAY $10.98
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- BWAY 50.25
- BDTX 35.88
- Support Level
- BWAY $8.90
- BDTX $2.12
- Resistance Level
- BWAY $9.49
- BDTX $2.35
- Average True Range (ATR)
- BWAY 0.32
- BDTX 0.15
- MACD
- BWAY 0.04
- BDTX 0.01
- Stochastic Oscillator
- BWAY 79.64
- BDTX 8.64
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.